Locating Herpesvirus Bcl-2 Homologs in the Specificity Landscape of Anti-Apoptotic Bcl-2 Proteins

Journal of Molecular Biology

Volumn 427, Issue 15, 2015, Pages 2468-2490

  Foight, Glenna Wink ^a   Keating, Amy E ^a,b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

bacterial surface display; BH3 peptides; BHRF1; KSBcl 2; peptide design

Indexed keywords

BCL2 RELATED PROTEIN A1; BH3 PROTEIN; BHRF1 PROTEIN; KSBCL 2 PROTEIN; M11 PROTEIN; PROTEIN BCL 2; PROTEIN BCL W; PROTEIN BCL XL; PROTEIN MCL 1; UNCLASSIFIED DRUG; VIRUS PROTEIN; BAX PROTEIN (53-86); BCL-2 PROTEIN, HUMAN HERPESVIRUS 8; BHRF1 PROTEIN, HUMAN HERPESVIRUS 4; M3 PROTEIN, MURINE GAMMAHERPESVIRUS; ONCOPROTEIN; PEPTIDE FRAGMENT; PROTEIN BINDING;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; HERPESVIRIDAE; HUMAN; NONHUMAN; PEPTIDE LIBRARY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN STRUCTURE; RECEPTOR BINDING; STRUCTURE ANALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; ENZYME SPECIFICITY; GENETICS; METABOLISM; MICROARRAY ANALYSIS; MOLECULAR GENETICS; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SEQUENCE HOMOLOGY;

BACTERIA (MICROORGANISMS); HERPESVIRIDAE; MAMMALIA;

AMINO ACID SEQUENCE; HUMANS; MICROARRAY ANALYSIS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN INTERACTION MAPS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SEQUENCE HOMOLOGY; SUBSTRATE SPECIFICITY; VIRAL PROTEINS;

EID: 84937815179     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2015.05.015     Document Type: Article

References (80)

1. B. Leber, J. Lin, and D.W. Andrews Embedded together: the life and death consequences of interaction of the Bcl-2 family with membranes Apoptosis 12 2007 897 911
2. J.E. Chipuk, T. Moldoveanu, F. Llambi, M.J. Parsons, and D.R. Green The BCL-2 family reunion Mol Cell 37 2010 299 310
3. A. Letai, M.C. Bassik, L.D. Walensky, M.D. Sorcinelli, S. Weiler, and S.J. Korsmeyer Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics Cancer Cell 2 2002 183 192
4. E. Yang, J. Zha, J. Jockel, L.H. Boise, C.B. Thompson, and S.J. Korsmeyer Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death Cell 80 1995 285 291
5. F. Llambi, T. Moldoveanu, S.W.G. Tait, L. Bouchier-Hayes, J. Temirov, L.L. McCormick, and et al. A unified model of mammalian BCL-2 protein family interactions at the mitochondria Mol Cell 44 2011 517 531
6. B.M. Polster, J. Pevsner, and J.M. Hardwick Viral Bcl-2 homologs and their role in virus replication and associated diseases Biochim Biophys Acta 1644 2004 211 227
7. L. Galluzzi, C. Brenner, E. Morselli, and Z. Touat Viral control of mitochondrial apoptosis PLoS Pathog 4 2008 e1000018
8. E. Xiaofei, S. Hwang, J. Oh, J.S. Lee, J.H. Jeong, Y. Gwack, and et al. Viral Bcl-2-mediated evasion of autophagy aids chronic infection of gammaherpesvirus 68 PLoS Pathog 5 2009 e1000609
9. A. Watanabe, S. Maruo, T. Ito, M. Ito, K.R. Katsumura, and K. Takada Epstein-Barr virus-encoded Bcl-2 homologue functions as a survival factor in Wp-restricted Burkitt lymphoma cell line P3HR-1 J Virol 84 2010 2893 2901
10. P.M. Ojala, M. Tiainen, P. Salven, T. Veikkola, E. Castaños-Vélez, R. Sarid, and et al. Kaposi's sarcoma-associated herpesvirus-encoded v-cyclin triggers apoptosis in cells with high levels of cyclin-dependent kinase 6 Cancer Res 59 1999 4984 4989
11. P.M. Ojala, K. Yamamoto, E. Castaños-Vélez, P. Biberfeld, S.J. Korsmeyer, and T.P. Mäkelä The apoptotic v-cyclin-CDK6 complex phosphorylates and inactivates Bcl-2 Nat Cell Biol 2 2000 819 825
12. A. Gelgor, I. Kalt, S. Bergson, K.F. Brulois, J.U. Jung, and R. Sarid KS-Bcl-2 encoded by the Kaposi's sarcoma-associated herpesvirus is vital for virus reactivation J Virol 2015 10.1128/JVI.00098-15
13. J.M. Hardwick, and D.S. Bellows Viral versus cellular BCL-2 proteins Cell Death Differ 10 2003 S68 S76
14. S. Gangappa, L.F. van Dyk, T.J. Jewett, S.H. Speck, and H.W. Virgin Identification of the in vivo role of a viral bcl-2 J Exp Med 195 2002 931 940
15. E.H.-Y. Cheng, J. Nicholas, D.S. Bellows, G.S. Hayward, H.-G. Guo, M.S. Reitz, and et al. A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak Proc Natl Acad Sci USA 94 1997 690 694
16. G.S. Taylor, and D.J. Blackbourn Infectious agents in human cancers: lessons in immunity and immunomodulation from gammaherpesviruses EBV and KSHV Cancer Lett 305 2011 263 278
17. J. Zuo, W.A. Thomas, T.A. Haigh, L. Fitzsimmons, H.M. Long, A.D. Hislop, and et al. Epstein-Barr virus evades CD4 T cell responses in lytic cycle through BZLF1-mediated downregulation of CD74 and the cooperation of vBcl-2 PLoS Pathog 7 2011 e1002455
18. F. Lantner, D. Starlets, Y. Gore, L. Flaishon, A. Yamit-Hezi, R. Dikstein, and et al. CD74 induces TAp63 expression leading to B-cell survival Blood 110 2007 4303 4311
19. O. Cojohari, C.M. Burrer, M.A. Peppenelli, F.A. Abulwerdi, Z. Nikolovska-Coleska, and G.C. Chan BH3 profiling reveals selectivity by herpesviruses for specific Bcl-2 proteins to mediate survival of latently infected cells J Virol 2015 10.1128/JVI.00236-15
20. J.M. Hardwick Cyclin' on the viral path to destruction Nat Cell Biol 2 2000 E203 E204
21. S. Pattingre, A. Tassa, X. Qu, R. Garuti, and X. Liang Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy Cell 122 2005 927 939
22. B. Ku, J.-S. Woo, C. Liang, K.-H. Lee, and H.-S. Hong Structural and biochemical bases for the inhibition of autophagy and apoptosis by viral BCL-2 of murine gamma-herpesvirus 68 PLoS Pathog 4 2008 e25
23. S. Dutta, S. Gullá, T.S. Chen, E. Fire, R.A. Grant, and A.E. Keating Determinants of BH3 binding specificity for Mcl-1 versus Bcl-xL J Mol Biol 398 2010 747 762
24. E. Fire, S. Gullá, R. Grant, and A. Keating Mcl-1-Bim complexes accommodate surprising point mutations via minor structural changes Protein Sci 19 2010 507 519
25. G.W. Foight, J.A. Ryan, S.V. Gullá, A. Letai, and A.E. Keating Designed BH3 peptides with high affinity and specificity for targeting Mcl-1 in cells ACS Chem Biol 9 2014 1962 1968
26. S. Zhang, A. Long, and A.J. Link A comparison of two strategies for affinity maturation of a BH3 peptide toward pro-survival Bcl-2 proteins ACS Synth Biol 1 2012 89 98
27. E.F. Lee, P.E. Czabotar, M.F. van Delft, E.M. Michalak, M.J. Boyle, S.N. Willis, and et al. A novel BH3 ligand that selectively targets Mcl-1 reveals that apoptosis can proceed without Mcl-1 degradation J Cell Biol 180 2008 341 355
28. E. Lee, A. Fedorova, K. Zobel, and M. Boyle Novel Bcl-2 homology-3 domain-like sequences identified from screening randomized peptide libraries for inhibitors of the pro-survival Bcl-2 proteins J Biol Chem 284 2009 31315 31326
29. L. Chen, S.N. Willis, A. Wei, B.J. Smith, J.I. Fletcher, M.G. Hinds, and et al. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function Mol Cell 17 2005 393 403
30. M. Certo, V. Del Gaizo Moore, M. Nishino, G. Wei, S. Korsmeyer, S.A. Armstrong, and et al. Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members Cancer Cell 9 2006 351 365
31. M. Vogler BCL2A1: the underdog in the BCL2 family Cell Death Differ 19 2012 67 74
32. A.M. Flanagan, and A. Letai BH3 domains define selective inhibitory interactions with BHRF-1 and KSHV BCL-2 Cell Death Differ 15 2008 580 588
33. Q. Huang, A. Petros, H. Virgin, and S. Fesik Solution structure of the BHRF1 protein from Epstein-Barr virus, a homolog of human Bcl-2 J Mol Biol 332 2003 1123 1130
34. S. Sinha, C.L. Colbert, N. Becker, Y. Wei, and B. Levine Molecular basis of the regulation of Beclin 1-dependent autophagy by the gamma-herpesvirus 68 Bcl-2 homolog M11 Autophagy 4 2008 989 997
35. T. Oltersdorf, S.W. Elmore, A.R. Shoemaker, R.C. Armstrong, D.J. Augeri, B.A. Belli, and et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours Nature 435 2005 677 681
36. A.W. Roberts, J.F. Seymour, J.R. Brown, W.G. Wierda, T.J. Kipps, S.L. Khaw, and et al. Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease J Clin Oncol 30 2012 488 496
37. C.M. Rudin, C.L. Hann, E.B. Garon, M. Ribeiro de Oliveira, P.D. Bonomi, D.R. Camidge, and et al. Phase II study of single-agent navitoclax (ABT-263) and biomarker correlates in patients with relapsed small cell lung cancer Clin Cancer Res 18 2012 3163 3169
38. A.J. Souers, J.D. Leverson, E.R. Boghaert, S.L. Ackler, N.D. Catron, J. Chen, and et al. ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets Nat Med 19 2013 202 208
39. S. Dutta, J. Ryan, T. Scott Chen, C. Kougentakis, A. Letai, and A.E. Keating Potent and specific peptide inhibitors of human pro-survival protein Bcl-xL J Mol Biol 427 2014 1241 1253
40. S. Dutta, T.S. Chen, and A.E. Keating Peptide ligands for pro-survival protein Bfl-1 from computationally guided library screening ACS Chem Biol 8 2013 778 788
41. E. Procko, G.Y. Berguig, B.W. Shen, Y. Song, S. Frayo, A.J. Convertine, and et al. A computationally designed inhibitor of an Epstein-Barr viral bcl-2 protein induces apoptosis in infected cells Cell 157 2014 1644 1656
42. M. Su, Y. Mei, R. Sanishvili, B. Levine, C.L. Colbert, and S. Sinha Targeting γ-herpesvirus 68 Bcl-2 mediated down-regulation of autophagy J Biol Chem 289 2014 8029 8040
43. T. Halgren New method for fast and accurate binding-site identification and analysis Chem Biol Drug Des 69 2007 146 148
44. T.A. Halgren Identifying and characterizing binding sites and assessing druggability J Chem Inf Model 49 2009 377 389
45. E.F. Lee, G. Dewson, M. Evangelista, A. Pettikiriarachchi, G.J. Gold, H. Zhu, and et al. The functional differences between pro-survival and pro-apoptotic B cell lymphoma 2 (Bcl-2) proteins depend on structural differences in their Bcl-2 homology 3 (BH3) domains J Biol Chem 289 2014 36001 36017
46. J. DeBartolo, M. Taipale, and A.E. Keating Genome-wide prediction and validation of peptides that bind human prosurvival Bcl-2 proteins PLoS Comput Biol 10 2014 e1003693
47. S. Dutta, S. Gullá, T. Chen, E. Fire, and R. Grant Determinants of BH3 binding specificity for Mcl-1 vs. Bcl-xL J Mol Biol 398 2010 747 762
48. J. DeBartolo, S. Dutta, L. Reich, and A.E. Keating Predictive Bcl-2 family binding models rooted in experiment or structure J Mol Biol 422 2012 124 144
49. N. London, S. Gullá, A.E. Keating, and O. Schueler-Furman In silico and in vitro elucidation of BH3 binding specificity toward Bcl-2 Biochemistry 51 2012 5841 5850
50. M. Boersma, J. Sadowsky, and Y. Tomita Hydrophile scanning as a complement to alanine scanning for exploring and manipulating protein-protein recognition: application to the Bim BH3 domain Protein Sci 17 2008 1232 1240
51. S. Zhang, and A.J. Link Bcl-2 family interactome analysis using bacterial surface display Integr Biol (Camb) 3 2011 823 831
52. E.F. Lee, P.E. Czabotar, B.J. Smith, K. Deshayes, K. Zobel, P.M. Colman, and et al. Crystal structure of ABT-737 complexed with Bcl-xL: implications for selectivity of antagonists of the Bcl-2 family Cell Death Differ 14 2007 1711 1713
53. Q. Huang, A.M. Petros, H.W. Virgin, S.W. Fesik, and E.T. Olejniczak Solution structure of a Bcl-2 homolog from Kaposi sarcoma virus Proc Natl Acad Sci USA 99 2002 3428 3433
54. M. Kvansakul, H. Yang, W.D. Fairlie, P.E. Czabotar, S.F. Fischer, M.A. Perugini, and et al. Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands Cell Death Differ 15 2008 1564 1571
55. G.J.P. Rautureau, M. Yabal, H. Yang, D.C.S. Huang, M. Kvansakul, and M.G. Hinds The restricted binding repertoire of Bcl-B leaves Bim as the universal BH3-only prosurvival Bcl-2 protein antagonist Cell Death Dis 3 2012 e443
56. A.L. Desbien, J.W. Kappler, and P. Marrack The Epstein-Barr virus Bcl-2 homolog, BHRF1, blocks apoptosis by binding to a limited amount of Bim Proc Natl Acad Sci USA 106 2009 5663 5668
57. J.M. Hardwick, Y.-B. Chen, and E.A. Jonas Multipolar functions of BCL-2 proteins link energetics to apoptosis Trends Cell Biol 22 2012 318 328
58. S. Erlich, L. Mizrachy, O. Segev, L. Lindenboim, O. Zmira, S. Adi-Harel, and et al. Differential interactions between Beclin 1 and Bcl-2 family members Autophagy 3 2007 561 568
59. T.S. Chen, and A.E. Keating Designing specific protein-protein interactions using computation, experimental library screening, or integrated methods Protein Sci 21 2012 949 963
60. G. Grigoryan, A.W. Reinke, and A.E. Keating Design of protein-interaction specificity gives selective bZIP-binding peptides Nature 458 2009 859 864
61. K. Tsao, B. Debarbieri, and H. Michel A versatile plasmid expression vector for the production of biotinylated proteins by site-specific, enzymatic modification in Escherichia coli Gene 169 1996 59 64
62. E. Lee, P. Czabotar, H. Yang, and B. Sleebs Conformational changes in BCL-2 pro-survival proteins determine their capacity to bind ligands J Biol Chem 284 2009 30508 30517
63. M.D. Herman, T. Nyman, M. Welin, L. Lehtiö, S. Flodin, L. Trésaugues, and et al. Completing the family portrait of the anti-apoptotic Bcl-2 proteins: crystal structure of human Bfl-1 in complex with Bim FEBS Lett 582 2008 3590 3594
64. M. Kvansakul, A.H. Wei, J.I. Fletcher, S.N. Willis, L. Chen, A.W. Roberts, and et al. Structural basis for apoptosis inhibition by Epstein-Barr virus BHRF1 PLoS Pathog 6 2010 e1001236
65. B. Ku, C. Liang, J.U. Jung, and B.-H. Oh Evidence that inhibition of BAX activation by BCL-2 involves its tight and preferential interaction with the BH3 domain of BAX Cell Res 21 2011 627 641
66. A.Y. Denisov, G. Chen, T. Sprules, T. Moldoveanu, P. Beauparlant, and K. Gehring Structural model of the BCL-w-BID peptide complex and its interactions with phospholipid micelles Biochemistry 45 2006 2250 2256
67. T.S. Chen, H. Palacios, and A.E. Keating Structure-based redesign of the binding specificity of anti-apoptotic Bcl-x(L) J Mol Biol 425 2013 171 185
68. J.A. Getz, T.D. Schoep, and P.S. Daugherty Peptide discovery using bacterial display and flow cytometry Methods Enzymol 503 2012 75 97
69. R. Hietpas, B. Roscoe, L. Jiang, and D.N.A. Bolon Fitness analyses of all possible point mutations for regions of genes in yeast Nat Protoc 7 2012 1382 1396
70. G.E. Crooks, G. Hon, J.-M. Chandonia, and S.E. Brenner WebLogo: a sequence logo generator Genome Res 14 2004 1188 1190
71. A. Sali, and T.L. Blundell Comparative protein modelling by satisfaction of spatial restraints J Mol Biol 234 1993 779 815
72. N. Eswar, B. Webb, M.A. Marti-Renom, M.S. Madhusudhan, D. Eramian, M.-Y. Shen, and et al. Comparative protein structure modeling using MODELLER Current Protocols in Protein Science, Chapter 2, Unit 2.9 2007 10.1002/0471140864.ps0209s50
73. M. Hinds, M. Lackmann, G. Skea, and P. Harrison The structure of Bcl-w reveals a role for the C-terminal residues in modulating biological activity EMBO J 22 2003 1497 1507
74. A. Petros, A. Medek, and D. Nettesheim Solution structure of the antiapoptotic protein bcl-2 Proc Natl Acad Sci USA 98 2001 3012 3017
75. P.E. Czabotar, E.F. Lee, G.V. Thompson, A.Z. Wardak, W.D. Fairlie, and P.M. Colman Mutation to Bax beyond the BH3 domain disrupts interactions with pro-survival proteins and promotes apoptosis J Biol Chem 286 2011 7123 7131
76. M. Sattler, H. Liang, D. Nettesheim, R.P. Meadows, J.E. Harlan, M. Eberstadt, and et al. Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis Science 275 1997 983 986
77. C. Smits, P.E. Czabotar, M.G. Hinds, and C.L. Day Structural plasticity underpins promiscuous binding of the prosurvival protein A1 Structure 16 2008 818 829
78. A. Petros, D. Nettesheim, Y. Wang, and E. Olejniczak Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies Protein Sci 9 2001 2528 2534
79. W. Feng, S. Huang, H. Wu, and M. Zhang Molecular basis of Bcl-xL's target recognition versatility revealed by the structure of Bcl-xL in complex with the BH3 domain of Beclin-1 J Mol Biol 372 2007 223 235
80. Q. Liu, T. Moldoveanu, T. Sprules, E. Matta-Camacho, N. Mansur-Azzam, and K. Gehring Apoptotic regulation by MCL-1 through heterodimerization J Biol Chem 285 2010 19615 19624